Stay Alert for Patients Taking a New, Injectable Migraine Prophylaxis Med
You may see some home med lists contain erenumab (Aimovig, AIM-oh-vig), a new subcutaneous biologic to PREVENT migraine in adults.
It blocks receptors for calcitonin gene-related peptide (CGRP)...a vasodilator and pain sensitizer that spikes during migraine attacks.
Expect other "CGRP antagonists" to be approved within a few months.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals